FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act
The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved Epidiolex for the treatment of seizures associated [...]